Status:

COMPLETED

Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura

Lead Sponsor:

Jennifer Keiser

Collaborating Sponsors:

Vector Borne & Neglected Tropical Disease Control Division, Ministry of Health, Uganda

Conditions:

Trichuriasis

Eligibility:

All Genders

6-12 years

Phase:

PHASE3

Brief Summary

The goal of this parallel open-label randomized controlled superiority trial is to demonstrate that co-administered ivermectin (200 µg/kg) plus albendazole (400 mg) is superior to albendazole (400 mg)...

Detailed Description

In view that efficacy of co-administered ivermectin (IVM) and albendazole (ALB) has been found to vary between different settings the rationale of this parallel open-label randomized controlled superi...

Eligibility Criteria

Inclusion

  • Written informed consent for participation signed from caregivers; and written assent by participants.
  • Agree to comply with study procedures, including provision of two stool samples at the beginning (baseline) and at follow-up assessment 14-21 days after treatment.
  • Willing to be examined by a study nurse/physician prior to treatment.
  • At least two slides of the quadruple Kato-Katz thick smears positive for T. trichiura.

Exclusion

  • Presence or signs of major systemic illnesses, e.g. body temperature ≥ 38°C, clinical malaria (fever + positive RDT) upon initial clinical assessment.
  • Recent use of anthelmintic drug (within past 4 weeks).
  • Attending other experimental research studies.
  • Known allergy to study medications (i.e. benzimidazole or ivermectin).

Key Trial Info

Start Date :

October 9 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 14 2023

Estimated Enrollment :

161 Patients enrolled

Trial Details

Trial ID

NCT06037876

Start Date

October 9 2023

End Date

November 14 2023

Last Update

April 10 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vector Borne & Neglected Tropical Disease Control Division, Ministry of Health

Kampala, Uganda, P.O.Box 1661